Company intelligence / Profile preview

AnodGen Bioceuticals

Ireland

Ownership: Private
Development stage: Other

Overview

AnodGen Bioceuticals is a newly established Irish CMO focused on manufacturing and distributing plant-derived APIs—especially cannabinoids—using Lexaria's DehydraTECH for improved bioavailability; involved in research collaborations but has not disclosed clinical trial results as it supplies ingredients rather than running trials.

Therapeutic areas: ImmunologyNeurology
Modalities: Small moleculeBiologic
Industry: Contract Manufacturing Organization

Partnerships

Lexaria Bioscience (license for DehydraTECH drug delivery technology)Two undisclosed US universities (MOUs for cannabinoid/plant-based research)

Beyond the preview

Go deeper on AnodGen Bioceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AnodGen Bioceuticals.

Explore the full profile